+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Herceptin Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
Herceptin Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
New

Herceptin Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 87 Pages
  • May 2025
  • Region: Global
  • Prof Research
  • ID: 6090511
Description Jump to:
Herceptin (trastuzumab) is a monoclonal antibody targeting HER2-positive cancers, primarily breast cancer and stomach/gastric cancer, with HER2-positive breast cancer accounting for 15-20% of 2.5 million new breast cancer cases globally in 2020. The market is driven by the high incidence of breast cancer, advancements in precision medicine, where targeted therapies constitute 40% of cancer treatments, and the increasing adoption of biosimilars, which have boosted usage by 30% in low-income countries. The aging population, improved diagnostics, and expanded access to oncology care further fuel demand. The global Herceptin market is estimated at USD 1.5-3.0 billion in 2025, with a compound annual growth rate (CAGR) of 3%-7% through 2030.

Regional Market Trends

  • North America: The U.S. leads with widespread HER2 testing and biosimilar adoption, while Canada focuses on oncology access in rural areas.
  • Europe: Germany, France, and the UK drive growth with robust reimbursement for biologics and biosimilars.
  • Asia Pacific: China and India see rising demand due to increasing breast cancer incidence, with Japan emphasizing precision oncology.
  • Rest of the World: Brazil expands public health access to biosimilars, while the Middle East invests in cancer care infrastructure.

Application Analysis

  • Breast Cancer: Expected growth of 3.2%-7.2%, driven by high HER2-positive prevalence. Trends focus on combination therapies with chemotherapy.
  • Stomach/Gastric Cancer: Projected growth of 2.8%-6.8%, linked to niche indications. Advances emphasize adjuvant use in advanced cases.

Type Analysis

  • Biologic: Expected growth of 2.5%-6.5%, valued for established efficacy. Trends highlight combination regimens.
  • Biosimilar: Projected growth of 3.5%-7.5%, favored for cost-effectiveness. Advances focus on expanding access in emerging markets.

Key Market Players

  • Roche: Pioneers Herceptin for HER2-positive cancers.
  • Amgen: Develops trastuzumab biosimilars for oncology.
  • Pfizer: Offers biosimilars to enhance affordability.
  • Samsung Bioepis: Focuses on cost-effective biosimilars.
  • Celltrion: Provides trastuzumab biosimilars for global markets.

Porter’s Five Forces Analysis

  • Threat of New Entrants: Moderate, due to high R&D costs and regulatory barriers, but biosimilars lower entry hurdles.
  • Threat of Substitutes: Moderate, with newer targeted therapies competing, though Herceptin remains a standard for HER2-positive cancers.
  • Bargaining Power of Buyers: High, as biosimilars increase price competition, giving hospitals leverage.
  • Bargaining Power of Suppliers: Low, with multiple providers of biologics manufacturing.
  • Competitive Rivalry: High, with biosimilar manufacturers competing on price and market access.

Market Opportunities and Challenges

Opportunities:

  • Addressing HER2-positive breast cancer, with 15-20% of 2.5 million cases.
  • Leveraging precision medicine, constituting 40% of cancer treatments.
  • Utilizing biosimilars, with 30% increased usage in low-income countries.
  • Supporting early diagnosis through HER2 testing programs.
  • Meeting demand from aging populations with higher cancer risk.
  • Expanding access in emerging markets via biosimilars.

Challenges:

  • High costs of biologics limiting access in low-income regions.
  • Competition from newer targeted therapies.
  • Regulatory delays for biosimilar approvals.
  • Price erosion due to widespread biosimilars.
  • Limited oncology infrastructure in developing regions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Herceptin Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Herceptin Market in North America (2020-2030)
8.1 Herceptin Market Size
8.2 Herceptin Market by End Use
8.3 Competition by Players/Suppliers
8.4 Herceptin Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Herceptin Market in South America (2020-2030)
9.1 Herceptin Market Size
9.2 Herceptin Market by End Use
9.3 Competition by Players/Suppliers
9.4 Herceptin Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Herceptin Market in Asia & Pacific (2020-2030)
10.1 Herceptin Market Size
10.2 Herceptin Market by End Use
10.3 Competition by Players/Suppliers
10.4 Herceptin Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Herceptin Market in Europe (2020-2030)
11.1 Herceptin Market Size
11.2 Herceptin Market by End Use
11.3 Competition by Players/Suppliers
11.4 Herceptin Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Herceptin Market in MEA (2020-2030)
12.1 Herceptin Market Size
12.2 Herceptin Market by End Use
12.3 Competition by Players/Suppliers
12.4 Herceptin Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Herceptin Market (2020-2025)
13.1 Herceptin Market Size
13.2 Herceptin Market by End Use
13.3 Competition by Players/Suppliers
13.4 Herceptin Market Size by Type
Chapter 14 Global Herceptin Market Forecast (2025-2030)
14.1 Herceptin Market Size Forecast
14.2 Herceptin Application Forecast
14.3 Competition by Players/Suppliers
14.4 Herceptin Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Roche
15.1.1 Company Profile
15.1.2 Main Business and Herceptin Information
15.1.3 SWOT Analysis of Roche
15.1.4 Roche Herceptin Revenue, Gross Margin and Market Share (2020-2025)
15.2 Amgen
15.2.1 Company Profile
15.2.2 Main Business and Herceptin Information
15.2.3 SWOT Analysis of Amgen
15.2.4 Amgen Herceptin Revenue, Gross Margin and Market Share (2020-2025)
15.3 Pfizer
15.3.1 Company Profile
15.3.2 Main Business and Herceptin Information
15.3.3 SWOT Analysis of Pfizer
15.3.4 Pfizer Herceptin Revenue, Gross Margin and Market Share (2020-2025)
15.4 Samsung Bioepis
15.4.1 Company Profile
15.4.2 Main Business and Herceptin Information
15.4.3 SWOT Analysis of Samsung Bioepis
15.4.4 Samsung Bioepis Herceptin Revenue, Gross Margin and Market Share (2020-2025)
15.5 Viatris
15.5.1 Company Profile
15.5.2 Main Business and Herceptin Information
15.5.3 SWOT Analysis of Viatris
15.5.4 Viatris Herceptin Revenue, Gross Margin and Market Share (2020-2025)
15.6 Celltrion
15.6.1 Company Profile
15.6.2 Main Business and Herceptin Information
15.6.3 SWOT Analysis of Celltrion
15.6.4 Celltrion Herceptin Revenue, Gross Margin and Market Share (2020-2025)
15.7 Biocon Limited
15.7.1 Company Profile
15.7.2 Main Business and Herceptin Information
15.7.3 SWOT Analysis of Biocon Limited
15.7.4 Biocon Limited Herceptin Revenue, Gross Margin and Market Share (2020-2025)
15.8 Shanghai Henlius Biotech
15.8.1 Company Profile
15.8.2 Main Business and Herceptin Information
15.8.3 SWOT Analysis of Shanghai Henlius Biotech
15.8.4 Shanghai Henlius Biotech Herceptin Revenue, Gross Margin and Market Share (2020-2025)
15.9 Prestige Biopharma
15.9.1 Company Profile
15.9.2 Main Business and Herceptin Information
15.9.3 SWOT Analysis of Prestige Biopharma
15.9.4 Prestige Biopharma Herceptin Revenue, Gross Margin and Market Share (2020-2025)
15.10 AryoGen Pharmed
15.10.1 Company Profile
15.10.2 Main Business and Herceptin Information
15.10.3 SWOT Analysis of AryoGen Pharmed
15.10.4 AryoGen Pharmed Herceptin Revenue, Gross Margin and Market Share (2020-2025)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Herceptin Report
Table Data Sources of Herceptin Report
Table Major Assumptions of Herceptin Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Herceptin Picture
Table Herceptin Classification
Table Herceptin Applications
Table Drivers of Herceptin Market
Table Restraints of Herceptin Market
Table Opportunities of Herceptin Market
Table Threats of Herceptin Market
Table COVID-19 Impact For Herceptin Market
Table Raw Materials Suppliers
Table Different Production Methods of Herceptin
Table Cost Structure Analysis of Herceptin
Table Key End Users
Table Latest News of Herceptin Market
Table Merger and Acquisition
Table Planned/Future Project of Herceptin Market
Table Policy of Herceptin Market
Table 2020-2030 North America Herceptin Market Size
Figure 2020-2030 North America Herceptin Market Size and CAGR
Table 2020-2030 North America Herceptin Market Size by Application
Table 2020-2025 North America Herceptin Key Players Revenue
Table 2020-2025 North America Herceptin Key Players Market Share
Table 2020-2030 North America Herceptin Market Size by Type
Table 2020-2030 United States Herceptin Market Size
Table 2020-2030 Canada Herceptin Market Size
Table 2020-2030 Mexico Herceptin Market Size
Table 2020-2030 South America Herceptin Market Size
Figure 2020-2030 South America Herceptin Market Size and CAGR
Table 2020-2030 South America Herceptin Market Size by Application
Table 2020-2025 South America Herceptin Key Players Revenue
Table 2020-2025 South America Herceptin Key Players Market Share
Table 2020-2030 South America Herceptin Market Size by Type
Table 2020-2030 Brazil Herceptin Market Size
Table 2020-2030 Argentina Herceptin Market Size
Table 2020-2030 Chile Herceptin Market Size
Table 2020-2030 Peru Herceptin Market Size
Table 2020-2030 Asia & Pacific Herceptin Market Size
Figure 2020-2030 Asia & Pacific Herceptin Market Size and CAGR
Table 2020-2030 Asia & Pacific Herceptin Market Size by Application
Table 2020-2025 Asia & Pacific Herceptin Key Players Revenue
Table 2020-2025 Asia & Pacific Herceptin Key Players Market Share
Table 2020-2030 Asia & Pacific Herceptin Market Size by Type
Table 2020-2030 China Herceptin Market Size
Table 2020-2030 India Herceptin Market Size
Table 2020-2030 Japan Herceptin Market Size
Table 2020-2030 South Korea Herceptin Market Size
Table 2020-2030 Southeast Asia Herceptin Market Size
Table 2020-2030 Australia Herceptin Market Size
Table 2020-2030 Europe Herceptin Market Size
Figure 2020-2030 Europe Herceptin Market Size and CAGR
Table 2020-2030 Europe Herceptin Market Size by Application
Table 2020-2025 Europe Herceptin Key Players Revenue
Table 2020-2025 Europe Herceptin Key Players Market Share
Table 2020-2030 Europe Herceptin Market Size by Type
Table 2020-2030 Germany Herceptin Market Size
Table 2020-2030 France Herceptin Market Size
Table 2020-2030 United Kingdom Herceptin Market Size
Table 2020-2030 Italy Herceptin Market Size
Table 2020-2030 Spain Herceptin Market Size
Table 2020-2030 Belgium Herceptin Market Size
Table 2020-2030 Netherlands Herceptin Market Size
Table 2020-2030 Austria Herceptin Market Size
Table 2020-2030 Poland Herceptin Market Size
Table 2020-2030 Russia Herceptin Market Size
Table 2020-2030 MEA Herceptin Market Size
Figure 2020-2030 MEA Herceptin Market Size and CAGR
Table 2020-2030 MEA Herceptin Market Size by Application
Table 2020-2025 MEA Herceptin Key Players Revenue
Table 2020-2025 MEA Herceptin Key Players Market Share
Table 2020-2030 MEA Herceptin Market Size by Type
Table 2020-2030 Egypt Herceptin Market Size
Table 2020-2030 Israel Herceptin Market Size
Table 2020-2030 South Africa Herceptin Market Size
Table 2020-2030 Gulf Cooperation Council Countries Herceptin Market Size
Table 2020-2030 Turkey Herceptin Market Size
Table 2020-2025 Global Herceptin Market Size by Region
Table 2020-2025 Global Herceptin Market Size Share by Region
Table 2020-2025 Global Herceptin Market Size by Application
Table 2020-2025 Global Herceptin Market Share by Application
Table 2020-2025 Global Herceptin Key Vendors Revenue
Figure 2020-2025 Global Herceptin Market Size and Growth Rate
Table 2020-2025 Global Herceptin Key Vendors Market Share
Table 2020-2025 Global Herceptin Market Size by Type
Table 2020-2025 Global Herceptin Market Share by Type
Table 2025-2030 Global Herceptin Market Size by Region
Table 2025-2030 Global Herceptin Market Size Share by Region
Table 2025-2030 Global Herceptin Market Size by Application
Table 2025-2030 Global Herceptin Market Share by Application
Table 2025-2030 Global Herceptin Key Vendors Revenue
Figure 2025-2030 Global Herceptin Market Size and Growth Rate
Table 2025-2030 Global Herceptin Key Vendors Market Share
Table 2025-2030 Global Herceptin Market Size by Type
Table 2025-2030 Herceptin Global Market Share by Type

Companies Mentioned

  • Roche
  • Amgen
  • Pfizer
  • Samsung Bioepis
  • Viatris
  • Celltrion
  • Biocon Limited
  • Shanghai Henlius Biotech
  • Prestige Biopharma
  • AryoGen Pharmed
  • Dr. Reddy’s Laboratories

Related Topics

Related Reports

Herceptin Market Size, Share & Trends Analysis Report By Product (Biosimilar, Biologic) By Application (Breast Cancer, Stomach/Gastric Cancer), By Payer (Commercial/Private, Public), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Herceptin Market Size, Share & Trends Analysis Report By Product (Biosimilar, Biologic) By Application (Breast Cancer, Stomach/Gastric Cancer), By Payer (Commercial/Private, Public), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Herceptin Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Herceptin Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 135 Pages
  • Global
From
Herceptin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Herceptin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Herceptin Biosimilar Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Herceptin Biosimilar Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 96 Pages
  • Global
From
HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032 - Product Image

HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • 276 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.